Literature DB >> 21543323

N-formyl peptide receptor 3 (FPR3) departs from the homologous FPR2/ALX receptor with regard to the major processes governing chemoattractant receptor regulation, expression at the cell surface, and phosphorylation.

Marie-Josèphe Rabiet1, Laurence Macari, Claes Dahlgren, François Boulay.   

Abstract

Among human N-formyl peptide chemoattractant receptors, FPR2/ALX and FPR3 share the highest degree of amino acid identity (83%), and trigger similar cell responses upon ligand binding. Although FPR2/ALX is a promiscuous receptor, FPR3 has only one specific high affinity ligand, F2L, and a more restricted tissue/cell distribution. In this study, we showed that FPR2/ALX behaved as the prototypical receptor FPR1. The agonist-dependent phosphorylation used a hierarchical mechanism with a prominent role of Ser(329), Thr(332), and Thr(335). Phosphorylation of FPR2/ALX was essential for its desensitization but the lack of phosphorylation did not result in enhanced or sustained responses. In contrast, resting FPR3 displayed a marked level of phosphorylation, which was only slightly increased upon agonist stimulation. Another noticeable difference between the two receptors was their subcellular distribution in unstimulated cells. Although FPR2/ALX was evenly distributed at the plasma membrane FPR3 was localized in small intracellular vesicles. By swapping domains between FPR2/ALX and FPR3, we uncovered the determinants involved in the basal phosphorylation of FPR3. Experiments aimed at monitoring receptor-bound antibody uptake showed that the intracellular distribution of FPR3 resulted from a constitutive internalization that was independent of C terminus phosphorylation. Unexpectedly, exchanging residues 1 to 53, which encompass the N-terminal extracellular region and the first transmembrane domain, between FPR2/ALX and FPR3 switched localization of the receptors from the plasma membrane to intracellular vesicles and vice versa. A clathrin-independent, possibly caveolae-dependent, mechanism was involved in FPR3 constitutive internalization. The peculiar behavior of FPR3 most probably serves distinct physiological functions that remain largely unknown.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21543323      PMCID: PMC3143635          DOI: 10.1074/jbc.M111.244590

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  46 in total

Review 1.  Regulation of G protein-coupled receptor trafficking.

Authors:  Z-Q D Xu; X Zhang; L Scott
Journal:  Acta Physiol (Oxf)       Date:  2007-05       Impact factor: 6.311

2.  Human mitochondria-derived N-formylated peptides are novel agonists equally active on FPR and FPRL1, while Listeria monocytogenes-derived peptides preferentially activate FPR.

Authors:  Marie-Josèphe Rabiet; Emilie Huet; François Boulay
Journal:  Eur J Immunol       Date:  2005-08       Impact factor: 5.532

3.  Clathrin adaptor AP2 regulates thrombin receptor constitutive internalization and endothelial cell resensitization.

Authors:  May M Paing; Christopher A Johnston; David P Siderovski; Joann Trejo
Journal:  Mol Cell Biol       Date:  2006-04       Impact factor: 4.272

Review 4.  International Union of Basic and Clinical Pharmacology. LXXIII. Nomenclature for the formyl peptide receptor (FPR) family.

Authors:  Richard D Ye; François Boulay; Ji Ming Wang; Claes Dahlgren; Craig Gerard; Marc Parmentier; Charles N Serhan; Philip M Murphy
Journal:  Pharmacol Rev       Date:  2009-06-04       Impact factor: 25.468

5.  The role of beta-arrestins in the formyl peptide receptor-like 1 internalization and signaling.

Authors:  Emilie Huet; François Boulay; Sophie Barral; Marie-Josèphe Rabiet
Journal:  Cell Signal       Date:  2007-05-29       Impact factor: 4.315

6.  Formyl peptide receptor-like 2 is expressed and functional in plasmacytoid dendritic cells, tissue-specific macrophage subpopulations, and eosinophils.

Authors:  Thalie Devosse; Aude Guillabert; Nicky D'Haene; Alix Berton; Patricia De Nadai; Sophie Noel; Maryse Brait; Jean-Denis Franssen; Silvano Sozzani; Isabelle Salmon; Marc Parmentier
Journal:  J Immunol       Date:  2009-04-15       Impact factor: 5.422

7.  Phosphorylation of protease-activated receptor-2 differentially regulates desensitization and internalization.

Authors:  Tiffany K Ricks; JoAnn Trejo
Journal:  J Biol Chem       Date:  2009-10-08       Impact factor: 5.157

8.  The C5a receptor (C5aR) C5L2 is a modulator of C5aR-mediated signal transduction.

Authors:  Claire E Bamberg; Charles R Mackay; Hyun Lee; David Zahra; Jenny Jackson; Yun Si Lim; Peter L Whitfeld; Stewart Craig; Erin Corsini; Bao Lu; Craig Gerard; Norma P Gerard
Journal:  J Biol Chem       Date:  2009-12-31       Impact factor: 5.157

9.  CXCR7 functions as a scavenger for CXCL12 and CXCL11.

Authors:  Ulrike Naumann; Elisabetta Cameroni; Monika Pruenster; Harsha Mahabaleshwar; Erez Raz; Hans-Günter Zerwes; Antal Rot; Marcus Thelen
Journal:  PLoS One       Date:  2010-02-11       Impact factor: 3.240

10.  The human complement fragment receptor, C5L2, is a recycling decoy receptor.

Authors:  Anne-Marie Scola; Kay-Ole Johswich; B Paul Morgan; Andreas Klos; Peter N Monk
Journal:  Mol Immunol       Date:  2008-12-18       Impact factor: 4.407

View more
  26 in total

Review 1.  New development in studies of formyl-peptide receptors: critical roles in host defense.

Authors:  Liangzhu Li; Keqiang Chen; Yi Xiang; Teizo Yoshimura; Shaobo Su; Jianwei Zhu; Xiu-wu Bian; Ji Ming Wang
Journal:  J Leukoc Biol       Date:  2015-12-23       Impact factor: 4.962

2.  The Concise Guide to PHARMACOLOGY 2013/14: G protein-coupled receptors.

Authors:  Stephen P H Alexander; Helen E Benson; Elena Faccenda; Adam J Pawson; Joanna L Sharman; Michael Spedding; John A Peters; Anthony J Harmar
Journal:  Br J Pharmacol       Date:  2013-12       Impact factor: 8.739

3.  Adaptive evolution of formyl peptide receptors in mammals.

Authors:  Yoshinori Muto; Stéphane Guindon; Toshiaki Umemura; László Kőhidai; Hiroshi Ueda
Journal:  J Mol Evol       Date:  2015-01-28       Impact factor: 2.395

4.  Functional characterization of three mouse formyl peptide receptors.

Authors:  Hui-Qiong He; Dan Liao; Zhen-Guo Wang; Zhong-Li Wang; Hu-Chen Zhou; Ming-Wei Wang; Richard D Ye
Journal:  Mol Pharmacol       Date:  2012-11-15       Impact factor: 4.436

5.  CFP-10 from Mycobacterium tuberculosis selectively activates human neutrophils through a pertussis toxin-sensitive chemotactic receptor.

Authors:  Amanda Welin; Halla Björnsdottir; Malene Winther; Karin Christenson; Tudor Oprea; Anna Karlsson; Huamei Forsman; Claes Dahlgren; Johan Bylund
Journal:  Infect Immun       Date:  2014-10-20       Impact factor: 3.441

Review 6.  Regulation of inflammation by members of the formyl-peptide receptor family.

Authors:  Keqiang Chen; Zhiyao Bao; Wanghua Gong; Peng Tang; Teizo Yoshimura; Ji Ming Wang
Journal:  J Autoimmun       Date:  2017-07-06       Impact factor: 7.094

7.  Identification of C-terminal phosphorylation sites of N-formyl peptide receptor-1 (FPR1) in human blood neutrophils.

Authors:  Walid S Maaty; Connie I Lord; Jeannie M Gripentrog; Marcia Riesselman; Gal Keren-Aviram; Ting Liu; Edward A Dratz; Brian Bothner; Algirdas J Jesaitis
Journal:  J Biol Chem       Date:  2013-07-19       Impact factor: 5.157

Review 8.  Regulation of inflammation by lipid mediators in oral diseases.

Authors:  S Sommakia; O J Baker
Journal:  Oral Dis       Date:  2016-08-04       Impact factor: 3.511

Review 9.  The role of formylated peptides and formyl peptide receptor 1 in governing neutrophil function during acute inflammation.

Authors:  David A Dorward; Christopher D Lucas; Gavin B Chapman; Christopher Haslett; Kevin Dhaliwal; Adriano G Rossi
Journal:  Am J Pathol       Date:  2015-03-17       Impact factor: 4.307

Review 10.  The N-Formyl Peptide Receptors and Rheumatoid Arthritis: A Dangerous Liaison or Confusing Relationship?

Authors:  Ilaria Mormile; Francesca Wanda Rossi; Nella Prevete; Francescopaolo Granata; Valentina Pucino; Amato de Paulis
Journal:  Front Immunol       Date:  2021-06-18       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.